IP Library Granted Patent US 7,608,397
Granted Patent B2
US 7,608,397 · App. 11/629,245 · Granted Oct 27, 2009

Method for determining biophysical properties

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,608,397
App. No.
11/629,245
Granted
Oct 27, 2009
Kind
B2
Abstract

The invention is a method for detecting a change in the conformational or energetic state of a molecular species, comprising the steps of: (i) immobilizing the molecular species, under conditions suitable for the reaction to occur; (ii) contacting at least part of the molecular species with a localized electromagnetic field; and (iii) detecting a change in dielectric constant during or after the reaction, to thereby detect a change in the conformational or energetic state of the molecular species.

Claims (24)

1. A method for detecting a change in the conformational or energetic state of a molecular species during or after a reaction, comprising the steps of:

(i) immobilizing the molecular species, under conditions suitable for the reaction to occur;

(ii) contacting at least part of the molecular species with a localized area of electromagnetic field enhancement; and

(iii) detecting a change in dielectric constant during or after the reaction, to thereby detect a change in the conformational or energetic state of the molecular species.

2. The method according to claim 1 , wherein the molecular species is immobilized to a solid support.

3. The method according to claim 1 , wherein the molecular species is a protein.

4. The method according to claim 1 , wherein the molecular species is a polynucleotide processive enzyme.

5. The method according to claim 4 , wherein a conformational change results from the interaction of the enzyme with a target polynucleotide.

6. The method according to claim 4 , wherein the enzyme is a polymerase.

7. The method according to claim 6 , wherein incorporation of each of the nucleotides A, T (U), G and C causes a characteristic change in the energetic state/conformation of the polymerase.

8. The method according to claim 1 , wherein the localized area of electromagnetic field enhancement is created by positioning the molecular species between first and second electrodes and applying an electrical signal to the first electrode.

9. The method according to claim 8 , wherein the first and second electrodes are spaced between 1 nm and 1mm apart.

10. The method according to claim 8 , wherein the electrical signal is an AC voltage of predetermined frequency.

11. The method according to claim 10 , wherein the frequency is between 1 Hz and 100 GHz.

12. The method according to claim 8 , wherein a change in the conformational or energy state of the molecular species is detected by measuring a change in the impedance of the electrodes.

13. The method according to claim 8 , wherein a change in the conformational or energy state of the molecular species is detected by measuring a change in the total capacitance of the electrodes.

14. The method according to claim 13 , wherein the capacitance is measured using an AC bridge.

15. The method according to claim 1 , wherein the localized area of electromagnetic field enhancement is created by an integrated plasmon wave concentrator, microfabricated on a metal layer capable of supporting surface plasmons.

16. The method according to claim 15 , wherein the plasmon wave concentrator comprises a sub-wavelength aperture surrounded by at least one linear groove, with dielectric layers above and below.

17. The method according to claim 16 , wherein the at least one linear groove is situated on both the upper and reverse sides of the metal layer.

18. The method according to claim 16 , wherein a change in the conformational or energy state of the molecular species is detected by creating a visible or infra-red laser incident to the metal layer(s) and measuring a change in the intensity of the light emitted from the sub-wavelength aperature.

19. The method according to claim 16 , wherein a change in the conformational or energy state of the molecular species is detected by creating a visible or infra-red laser incident to the metal layer(s) and measuring the phase shift of light emitted from the sub-wavelength aperture as it passes through a concentrator structure.

20. The method according to claim 16 , wherein a change in the conformational or energy state of the molecular species is detected by creating a broad-band electromagnetic beam incident to the metal layer(s) and measuring a change in the wavelength of light emitted from the sub-wavelength aperature.

21. The method according to claim 1 , wherein the localized area of electromagnetic field enhancement is created by a metalized scanning probe microscope or atomic force microscope tip, on a surface plasmon supporting surface.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO BIOLUCENT, LLC; CYTYC SURGICAL PRODUCTS, LLC, AS SUCCESSOR-BY-CONVERSION TO CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; GEN-PROBE INCORPORATED, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 075566/0039 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 028810 FRAME: 0745. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 035820 FRAME: 0239. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST RELEASE. Recorded Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 044727/0529 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE REEL/FRAME 028810/0745 Recorded Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 035820/0239 →
SECURITY AGREEMENT Recorded Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2010
From: MEDICAL BIOSYSTEMS LIMITED
To: REJUVIGEN LIMITED
Reel/Frame 024896/0283 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2010
From: MOBIOUS BIO SYSTEMS LIMITED
To: GEN-PROBE INCORPORATED
Reel/Frame 024896/0309 →
CHANGE OF NAME Recorded Aug 27, 2010
From: REJUVIGEN LIMITED
To: MOBIOUS BIOSYSTEMS LIMITED
Reel/Frame 024896/0336 →